Nature Reviews Immunology (2020) https://doi.org/10.1038/s41577-020-0320-7 Published online 23 April 2020
In the originally published article, Cecilia Garlanda’s affiliations were incompletely listed as 5Humanitas Clinical and Research Center, Milan, Italy and 6Humanitas University, Milan, Italy.
These have now been corrected to 5Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy and 6Humanitas University, Pieve Emanuele, Milan, Italy.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Risitano, A.M., Mastellos, D.C., Huber-Lang, M. et al. Author Correction: Complement as a target in COVID-19?. Nat Rev Immunol 20, 448 (2020). https://doi.org/10.1038/s41577-020-0366-6
Published:
Issue date:
DOI: https://doi.org/10.1038/s41577-020-0366-6
This article is cited by
-
Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
Molecular and Cellular Biochemistry (2021)
